About Proclara Biosciences

Proclara is a clinical-stage biotechnology company pioneering a breakthrough approach to treating neurodegenerative and peripheral protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by Alzheimer’s, Parkinson’s, and systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.